ArticlePloS one2024

Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.

Tan Boon Toh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.